The Recall Desk
Agency classClass IIOur severity:ModerateFDA (Drugs)·D-0539-2018·Announced 2018-02-28

Fluticasone Propionate USP Recalled for Missing Stability Data

American Pharmaceutical Ingredients LLC is recalling Fluticasone propionate USP for prescription compounding due to a lack of stability data and controls to support expiration dates.

The agency’s classification

FDA (Drugs): Class II

Class II is a situation in which use of or exposure to a violative product may cause temporary or medically reversible adverse health consequences, or where the probability of serious adverse health consequences is remote.

This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work

What this means for you

Our assessment, not the agency’s: severity 2/5 (Moderate).

Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.

Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of, or exposure to, a violative product may cause temporary or medically reversible adverse health consequences. The specific hazard is a documentation and stability control issue rather than a direct contamination or acute injury risk.

Plain-English summary

American Pharmaceutical Ingredients LLC is recalling Fluticasone propionate USP (Micronized) for prescription compounding. The product is available in 1g, 10g, 25g, and 100g packages and is distributed nationwide within the USA. The recall is due to Current Good Manufacturing Practice (CGMP) deviations, specifically a lack of stability data and controls to support the manufacturers assigned retest or expiration date in the firm's container/closure system.

This recall affects specific lots of the product with expiration dates ranging from April 30, 2020, to December 31, 2020. The affected lot numbers include 052615-2, 020916-1, 092115-1, 092115-2, 110315-3, and 110315-2. The product is intended for prescription use only.

Consumers and healthcare providers should check their inventory for these specific lot numbers and expiration dates. If the product is found, it should be returned to the supplier or disposed of according to local regulations. No specific instructions for patient management are provided in the source text.

The recalled product

Product
Fluticasone propionate USP (Micronized) for prescription compounding, packaged in a) 1g (NDC (58597-8276-1), b) 10g (NDC 58597-8276-3), c) 25g (NDC 58597-8276-4), d) 100g (NDC 58597-8276-6), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road…
Manufacturer
American Pharmaceutical Ingredients LLC
Category
Drug — Pharmaceutical Ingredient
Hazard

Is your product affected?

Check your packaging against the codes below. If any of them match, the product is part of this recall.

Lot numbers (12)

  • Lot #: a) 052615-2
  • Exp. 4/30/2020
  • 020916-1
  • Exp. 12/31/2020
  • b) 092115-1
  • Exp. 8/31/2020
  • 092115-2
  • 110315-3
  • Exp. 9/30/2020
  • c) 020916-1
  • 110315-2
  • d) 020916-1

Distribution

Distributed nationwide across the United States.

Part of a larger recall action

This product is one of 66 recalled by American Pharmaceutical Ingredients LLC under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.

See all 66 products in this recall →

Related recalls

Same manufacturer · American Pharmaceutical Ingredients LLC

See all →

Same hazard · stability data

See all →

Similar recalls